The Blumberg Institute and Hepatitis B Foundation mourn the passing of John C. Martin, pharmaceutical industry leader. <<click here>>

Distinguished Speaker Seminars

Please note: Registration is free. Remember to check “autosubscribe” when registering to automatically sign up for future seminars. Also, please bookmark our website to check for future speakers. Important: For the best viewing experience, Google Chrome is the recommended browser. Firefox and Safari also will work. Recordings of recent seminars are posted below.

 

BLUMBERG PRIZE LECTURE

April 30 - 9 a.m. EDT - Wenhui Li, Ph.D.

Investigator, National Institute of Biological Sciences (NIBS) Beijing, China

2021 Blumberg Prize Recipient

 Register here.

 

RECENT SEMINARS

 

March 18 - 11 a.m. EDT - Lei Wei, Ph.D., Fellow, Department of Molecular Biology, Princeton University

"Making a murderer - Formation of Hepatitis B virus (HBV) Genomic cccDNA"

A recording is posted here.

 

Feb. 4, 2021 - Aleem Siddiqui, Ph.D., Division of Infectious Diseases and Global Public Health, University of California, San Diego

"Regulation of HBV/HCV infection by N6-methyladenosine modification"

A recording is posted here. 

 

 Jan. 21, 2021  - Ronald T. Hay, Ph. D., Centre for Gene Regulation and Expression, University of Dundee

"Molecular basis of arsenic treatment for acute promyelocytic leukaemia"

A recording is posted here. 

 

Jan. 14, 2021 - Emilio A. Emini, Ph.D., FCPP, FAAM, Director TB and HIV Program Bill & Melinda Gates Foundation

"Controlling the Global HIV and TB Epidemics: Challenges and Opportunities" 

Co-hosted by the Pennsylvania Drug Discovery Institute

A recording is posted here.

 

Dec. 10, 2020 - Dongfang Liu, MBBS, Ph.D, Professor of Pathology, Rutgers N.J. School of Medicine

"Natural Killer (NK) cells from basic immunobiology to clinical application"

A recording is posted here.

 

Dec. 3 - Stephan Urban, Ph.D., Department of Infectious Diseases, Heidelberg University Hospital

"Inhibitor of entry as a therapeutic for hepatitis B and D"

A recording will be posted here shortly.

 

Oct. 1  - Nicholas van Buuren, Ph.D., Gilead Sciences

"Integrated HBV DNA: Investigation of the Architecture and Potential Clinical Implications."

A recording is posted here.

 

Sept. 13 - Rudolf K. Beran, Ph.D., Gilead Sciences 

“Characterizing the interplay between hepatitis B virus X protein and Smc5/6."

A recording is posted here.

 

Aug. 13 - V. Narry Kim, M.S., D.Phil, Professor, Seoul National University

"Viral hijacking of host functions to protect viral RNA"

A recording is posted here.

 

July 16 - Andrew Vaillant, Ph.D., Chief Scientific Officer, Replicor Inc.

"Understanding HBsAg and subviral particles: key players in chronic HBV infection and key targets in achieving functional cure of HBV."

A recording is posted here.

 

June 30 - Marion Peters, M.D., University of California, San Francisco

Bruce Witte Distinguished Lecture, "Precision Medicine for Chronic Hepatitis B"

A recording is posted here.

 

June 18 - Scott L. Friedman, M.D., Icahn School of Medicine, N.Y.C.

"Mechanisms of Fibrosis Development in NAFLD and Therapeutic Strategies"

A recording is posted here.

 

June 4 -  Mala Maini, M.D., University College, London

"Immunobiology of Chronic Hepatitis B"  

A recording is posted here: